is no data on fetal thymus size in pregnancies complicated by maternal diabetes. Therefore, the objective of our study was to evaluate the influence of maternal diabetes on fetal thymus size. Methods: We retrospectively assessed 161 pregnancies of diabetic mothers and 161 uncomplicated pregnancies matched by gestational age (control group). Diabetic mothers were allocated to three different groups: 1. diet-controlled gestational diabetes, 2. Insulin-dependent gestational diabetes, and 3. pre-existing diabetes. The anteroposterior thymic and the intrathoracic mediastinal diameter were measured and we calculated the quotient as thymic-thoracic ratio (TT-ratio). Furthermore, we defined the thymus-head ration (TH-ratio) as the quotient of the anteroposterior thymic diameter and the circumference of the fetal head. Results: TT-and TH-ratios were significantly smaller in pregnancies with maternal diabetes (P < 0.001 and P < 0.001, respectively). In all three diabetes groups, both ratios were lower when compared to the control group (P < 0.001). Conclusions: TT-and TH-ratios were significantly smaller in pregnancies with maternal diabetes (P < 0.001 and P < 0.001, respectively). In all three diabetes groups, both ratios were lower when compared to the control group (P < 0.001).
OP21.09
Fetal Dopplers for prediction of perinatal outcomes in pregnancies complicated by gestational diabetes mellitus
Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy
Objectives: Women with gestational diabetes mellitus (GDM) are at increased risk for various adverse outcomes thus leading to an increase in operative delivery for reasons as cephalopelvic disproportion, fetal distress and non reassuring fetal heart trace.
Induction of labour (IOL) at term is often proposed for these patients but recent studies show that IOL results in similar risk as expectant management between 37-40 weeks and the recent WHO guidelines state that if GDM is the only abnormality, IOL before 41 weeks of gestation is not recommended (weak strength).
Retrospective studies showed how fetal Dopplers at term can be predictive of adverse pregnancy outcomes including stillbirth and perinatal morbidity in normal pregnancies.
The aim of the present study is to evaluate the role of Uterine Artery (UA) PI, Middle Cerebral Artery (MCA) PI and Cerebroplacental ratio (CPR) for prediction of pregnancy outcomes in patients affected by GDM. Methods: Prospective cohort study in a single centre.
Evaluation of UA PI, MCA PI and CPR at > 37 weeks' gestation in singleton, morphologically normal pregnancies affected by GDM has been performed in order to estimate the association between ultrasound measurements at term and perinatal outcome.
Regression linear analysis and multivariate logistic regression analysis were used to estimate the association between fetal Dopplers and neonatal pH, neonatal Apgar score and mode of delivery. Results: Our preliminary results on 70 women showed MCA PI to be the best predictor of perinatal outcome in terms of low neonatal weight (p<0.0002). A significant correlation has been also demonstrated for pH and low Apgar score at the 1st minute (p<0.05). No significant correlations for UA PI and CPR MoMs have been demonstrated in our population. However, the small sample size is a limitation of the study. Conclusions: Evaluation of MCA at term can be a useful tool to discriminate pregnancies affected by GDM that can benefit from IOL before 41 weeks in order to reduce complications related to this condition. Objectives: Non-invasive prenatal testing (NIPT) has provided unprecedented opportunities for sex chromosome aneuploidy (SCA) detection; however, routine inclusion of SCA screening into prenatal care is controversial. We aimed to assess trends in the prenatal diagnosis of SCA before and after the introduction of NIPT in a state population with > 73,000 annual births. Methods: We analysed prospectively-collected data on all women undergoing amniocentesis or chorionic villus sampling before 25 weeks gestation from 1986-2015 in Victoria, Australia. Women with a prenatal diagnosis of whole chromosome SCA were included. Indications for testing from three triennia (1986-88, 2002-04 and 2013-15) were analysed to assess trends in ascertainment of SCA. Statistical significance was tested using the chi-square test for trend. Results: There were 1,960,453 births and 780 prenatal diagnoses of SCA from 1986-2015. The annual rate of SCA per 10,000 births increased significantly over the 30-year period (p<0.001) but remained steady after the introduction of NIPT in 2013 (p=0.71). However, due to the recent decline in invasive testing associated with NIPT, the proportion of diagnostic tests resulting in a SCA diagnosis increased significantly from 0.9% in 2010 to 1.4% in 2015 (p=0.006). The most common indications for diagnostic testing among women with fetal SCA have changed from advanced maternal age (58% of indications) and ultrasound abnormality (25%) in 1986-88, to ultrasound abnormality (45%) and high risk of SCA on NIPT (25%) in 2013-15. Conclusions: The introduction of NIPT for sex chromosomes has not been associated with a significant increase in the detection of prenatal SCA as a proportion of all births in our population. However, the ascertainment of fetal SCA has changed substantially, from an ''incidental'' finding after testing for Down syndrome based on advanced maternal age, to a diagnosis obtained after abnormal ultrasound or suspected SCA on NIPT. Pre-test counselling for SCA is now more important than ever.
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OP22.02
The determination of fetal sex using cell-free DNA testing M. Hynek, F. Zembol, I. Maresova, M. Bittóova, D. Stejskal
Fetal Medicine, GENNET, Prague, Czech Republic
Objectives: The aim of this study was to assess the determination of fetal sex with non-invasive cell-free DNA (cfDNA) testing using a proposed novel tool, a number of occupied bins on chromosome Y (NoYbins) and compared it with the traditional tool, the proportion of the unique reads mapped to chromosome Y (%chrY). Methods: The study group resulted from a larger prospective cfDNA study in which our in-house cfDNA test was routinely performed in singleton pregnancies with the risk for trisomies from the first-trimester combined test between 1/100-1/500. For each sample, cfDNA was isolated from maternal plasma and whole-genome sequencing using Ion Proton System platform was performed. The fetal sex was assessed using two tools: NoYbins and %chrY. Fetal sex was confirmed by ultrasound, invasive testing or after delivery. Results: A total of 2,818 prenatal samples was processed between January 2015 and March 2017. 150 samples were excluded due to insufficient number of reads, high GC bias or unknown pregnancy outcome. Therefore, 2,668 samples were eligible for the designed analysis. In case of NoYbins, the values of male and female fetuses were widely separated (male fetuses ranged 81-254, female 5-25), compared to %chrY (male fetuses ranged 0.00647-0.0631, female 0.00246-0.00773) where a small overlap was noticed. Moreover, the assessment of NoYbins allowed to identify three atypical cases with abnormal outcomes which values presented clearly between the ranges of male and female fetuses (Case 1 was clinically consistent with triploidy, Case 2 with confirmed triploidy, Case 3 with confirmed Turner syndrome). Considering the %chrY, the values of these three cases fell within the range of normal female fetuses.
Conclusions:
The proposed approach with NoYbins has an excellent ability to determine fetal sex with a sensitivity and specificity of 100%. Moreover, the advantage of this tool is that it allows to identify the atypical cases with a high risk of associated anomaly. Objectives: The objective of this study was to analyse the uptake of SCA screening after pre-test genetic counselling among women who had NIPT and determine the performance of NIPT for SCA in our sample population. Methods: A large obstetrics and gynecology ultrasound practice (Monash Ultrasound for Women -MUFW) from Melbourne, Australia, has offered NIPT (Harmony TM ) since March 2013. All women referred to non-invasive prenatal testing (NIPT) between 10-11 weeks had a pre-test viability/dating scan and genetic counselling, where SCA screening was discussed and offered as an optional panel. A first trimester morphogy scan at 12-13 weeks was offered to all, together with NIPT post-testing counselling. Invasive procedure (CVS/amniocentesis) was offered to all high risk cases. Results: Data from 5409 mixed-risk women who had NIPT between March 2013 and December 2015 was analysed. Of those who were eligible for SCA screening, 19.7% were IVF conceptions. Overall, 20% of women declined SCA screening following genetic counselling. Method of conception and a priori risk did not influence uptake of SCA screening. Of those who had SCA screening, 36 received a high-risk assessment: 16.7% true positives, 47.3% false positives, 36% declined further testing. The false positive rate for the SCA panel was significantly higher than the false positive rates for the autosomal aneuploidies and the addition of SCA panel increased the screen positive rate in 1%. Conclusions: Given the high rate of women declining SCA screening, the low uptake of invasive procedure after a high risk result and the low number of true positive results observed on our sample, we conclude that pre-test counselling is essential and SCA screening should continue to be offered as an optional aspect of NIPT.
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Non-invasive prenatal testing (NIPT) for 22q11.2 deletion syndrome using a targeted microarray-based cell-free DNA (cfDNA) test M. Schmid, E. Wang, P. Bogard, J. Zahn, C. Hacker, R. Stokowski, S. Wang, K. White, A. Sparks
